ALLOVIR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8164 USD | +4.43% |
|
+1.23% | +20.09% |
| 03-20 | North American Morning Briefing : Markets on Hold -2- | DJ |
| 03-15 | AlloVir, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar AlloVir, Inc.
a1a45a8635b9ef27699ba.NEiGyj5IizWS0Qikd_cA8ZF3d9ZA3SFzWLPqX3WZLW0.RR7RvBMm5WTTnD2QFJAtx_cwOuIuuFIHM_2vFyTfWzJZCsu9RATiRNG8TQ~aa846be7ed703085944c369efe9932bb
Upcoming events on AlloVir, Inc.
Past events on AlloVir, Inc.
| 2024-05-01 | Q1 2024 Earnings Release (Projected) |
| 2023-11-28 10:00 | Piper Sandler Healthcare Conference |
| 2023-11-02 07:00 | Q3 2023 Earnings Release |
| 2023-09-12 12:00 | H.C. Wainwright Global Investment Conference |
| 2023-09-11 16:55 | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 2023-08-03 07:00 | Q2 2023 Earnings Release |
| 2023-05-11 09:00 | Annual General Meeting |
| 2023-05-09 11:40 | Bank of America Healthcare Conference - Fireside Chat |
| 2023-05-04 07:00 | Q1 2023 Earnings Release |
| 2023-02-15 09:00 | Posoleucel Phase 2 Study Results Call |
| 2023-02-15 07:07 | FY 2022 Earnings Release |
| 2023-02-14 10:00 | SVB Securities Global Biopharma Conference |
| 2023-01-10 17:15 | JP Morgan Healthcare Conference |
| 2022-12-14 16:30 | Business Update Call |
| 2022-12-10 17:15 | American Society of Hematology Meeting |
| 2022-11-29 12:00 | Piper Sandler Healthcare Conference |
| 2022-11-04 | American Society of Nephrology Kidney Week Conference - Abstract SA-PO849 |
| 2022-11-03 07:00 | Q3 2022 Earnings Release |
| 2022-09-14 12:20 | Morgan Stanley Global Healthcare Conference |
| 2022-08-04 07:00 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,17 | 0,00 0,38 - | 0,00 0,38 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -71,2 -70,3 -1.36% | -170 -153 -11.11% | -170 -174 1.75% | -200 -189 -5.62% | -53,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -71,3 -72,3 1.36% | -170 -160 -5.95% | -171 -177 3.43% | -200 -189 -5.51% | -60,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -69,8 -71,9 2.97% | -171 -165 -3.71% | -169 -180 6.01% | -191 -179 -6.44% | -41,0 |
|
Net income Million USD | Released Forecast Spread | -23,8 | -69,8 -72,1 3.19% | -172 -165 -4.23% | -169 -181 6.88% | -190 -180 -5.8% | -41,6 |
|
EPS USD | Released Forecast Spread | -12,4 | -2,59 -4,52 42.64% | -2,74 -2,64 -3.93% | -2,20 -2,25 2.08% | -1,83 -1,73 -5.83% | -0,36 |
| Announcement Date | 03/06/20 | 11/02/21 | 10/02/22 | 15/02/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -55,7 -49,0 -13.68% | -44,5 -48,0 7.21% | -42,9 -47,0 8.8% | -40,3 -45,0 10.34% | -47,2 -44,0 -7.32% | -46,9 -44,0 -6.53% | -62,3 -47,0 -32.48% | -22,0 | -11,0 | -5,00 | -3,00 | |||
|
EBIT Million USD | Released Forecast Spread | -55,8 -52,1 -7.15% | -43,2 -50,5 14.47% | -44,6 -47,6 6.15% | -43,0 -48,8 11.9% | -40,4 -49,5 18.32% | -43,2 -43,3 0.04% | -47,3 -45,9 -3.17% | -47,0 -45,3 -3.59% | -69,2 -53,2 -30.09% | -22,0 | -11,0 | -5,00 | -3,00 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,9 -50,8 -12.03% | -43,9 -51,1 14.11% | -44,5 -47,9 7.09% | -42,1 -48,7 13.58% | -38,6 -49,1 21.42% | -41,2 -43,0 4.16% | -45,3 -44,8 -0.98% | -44,3 -46,0 3.72% | -59,8 -48,7 -22.95% | -22,0 | -11,0 | -5,00 | -3,00 | |
|
Net income Million USD | Released Forecast Spread | -57,9 -50,8 -14.01% | -43,9 -50,5 13.19% | -44,6 -47,1 5.15% | -42,1 -46,8 10.18% | -38,1 -50,5 24.5% | -41,2 -42,9 3.94% | -45,3 -44,1 -2.62% | -44,3 -44,0 -0.59% | -59,8 -48,8 -22.55% | -19,4 | -11,4 | -9,38 | -8,71 | |
|
EPS USD | Released Forecast Spread | -0,92 -0,81 -12.95% | -0,69 -0,80 13.32% | -0,69 -0,73 5.52% | -0,50 -0,53 5% | -0,37 -0,54 31.9% | -0,44 -0,46 4.68% | -0,48 -0,44 -9.06% | -0,39 -0,40 2.86% | -0,53 -0,43 -24% | -0,17 | -0,10 | -0,08 | -0,07 | |
| Announcement Date | 10/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 15/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/03/24 | - | - | - | - | - |
More events
Past sector events for AlloVir, Inc.
| Today | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 16:15 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:10 | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:09 | XENCOR, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:02 | SPYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:01 | MACROGENICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:01 | ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release |
| 2024-05-09 16:00 | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:00 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release |
| 2024-05-09 07:30 | WAVE LIFE SCIENCES LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVR Stock
- Calendar AlloVir, Inc.